SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 2.800+13.8%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (963)1/25/1999 2:46:00 PM
From: SteveR  Read Replies (1) of 2539
 
Not to pick a nit, however from the article:

>Furthermore, the company faces hefty expenditures for marketing
>(Celebrex launch), restructuring (seed company acquisitions) and
>research (half a dozen late-stage clinical trials) in the next few
>years.

It's not that MTC will have hefty expenditures for marketing, however they will split the profit with Phizer for their worldwide marketing of the product.

stever
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News